1.Risk Factor Assessment Using Surface Electromyography and Electrogoniometer among Automobile Part Manufacturers.
Dongmug KANG ; Cheol Ho YEE ; Yong Chul SHIN ; Eun A KIM ; Ji Hoon WOO ; Byung Mann CHO ; Su Ill LEE
Korean Journal of Occupational and Environmental Medicine 2005;17(4):267-277
OBJECTIVES: As automobile part manufacturing is characterized by high speed and high repetition, observation methods which are usually utilized for static posture are inappropriate to evaluate musculoskeleatal risk factors. This study quantified the risk factors of musculoskeletal disorders on the forearm and suggested exposure limits by estimating the risk factors using surface electromyography (EMG) and electrogoniometer. METHODS: Ten percent of the total workers at 3 automobile part manufacturing factories were randomly selected, and 99 male workers were recruited as study subjects. The study was conducted during May 2003 to September 2004. The workers were equipped with electrogoniometers on the wrist and the elbow, surface EMGs on the skin of the flexor digitorum superficialis (FDS) and extensor carpi radialis (ECR) muscles, and the heart beat recorder during work as indicators of joint movement, local muscle tension and physical work load, respectively. RESULTS: After controlling for age, body mass index and job stress, wrist flexion maximum angle, FDS relative activity (RA) and ECR RA were significantly associated with forearm musculoskeletal symptoms. The odds ratios of the forearm were 5.0(95% CI: 1.1-22.7), 14.0(95% CI: 1.5-128.8) and 7.3(95% CI: 1.1-49.4) for wrist flexion maximum angle more than 76 degrees, FDS RA more than 2.8%, and ECR RA more than 3.5%, respectively. CONCLUSIONS: Joint angle and focal muscle activity were associated with forearm musculoskeletal symptoms. To reduce forearm musculoskeletal symptoms among automobile part manufacturers, the wrist flexion angle, and FDS and ECR activity need to be reduced below the guidelines recommended in this study.
Automobiles*
;
Body Mass Index
;
Elbow
;
Electromyography*
;
Forearm
;
Heart
;
Humans
;
Joints
;
Male
;
Muscle Tonus
;
Muscles
;
Odds Ratio
;
Posture
;
Risk Factors*
;
Skin
;
Wrist
2.Acetabular Revision Using Uncemented Acetabular Cup.
Yee Suk KIM ; Young Ho KIM ; Kee Cheol PARK ; Chang Hoon LEE ; Il Yong CHOI
Journal of the Korean Hip Society 2009;21(1):53-59
PURPOSE: The purpose of this study is to evaluate the clinical and radiological results of revision total hip arthroplasty with using impacted bone grafts and uncemented acetabular cups on the acetabulum with bone defects. MATERIALS AND METHODS: From June 1990 to March 2006, 131 revision total hip arthroplasties using an uncemented acetabular cup and impacted bone graft, were performed in 124 patients. The average follow-up period was 66 months. The clinical results were evaluated with the Harris hip score. The radiological results included the period of graft incorporation, the rate of resorption, the migration and the change of inclination of the cup. The failure rate and 13 year survival rate were analyzed. RESULTS: The Harris hip scores were 51.8 preoperatively and 82.5 postoperatively. The period of incorporation was a mean of 6.38 month. Most cases showed a resorption rate below 10%. The mean migrations of the acetabular cup were 1.37 mm superiorly and 1.20 mm medially. The mean change of inclination was 1.24 degrees. There were 5 re-revision surgeries. The failure rate was 3.8%. The survival rate of the revision that was done due to loosening was 94.9% at 13 years. CONCLUSION: Acetabular revision arthroplasty with bone grafts, and an uncemented cup is recommendable as it achieves favorable outcomes in terms of rapid incorporation of the grafted bone and stable fixation of the cup.
Acetabulum
;
Arthroplasty
;
Follow-Up Studies
;
Hip
;
Humans
;
Survival Rate
;
Transplants
3.12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity.
Jin Wook LEE ; Ho Cheol RYU ; Yee Ching NG ; Cheolmin KIM ; Jun Dong WEI ; Vikineswary SABARATNAM ; Jae Hong KIM
Experimental & Molecular Medicine 2012;44(6):378-386
12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) is an enzymatic product of prostaglandin H2 (PGH2) derived from cyclooxygenase (COX)-mediated arachidonic acid metabolism. Despite the high level of 12-HHT present in tissues and bodily fluids, its precise function remains largely unknown. In this study, we found that 12-HHT treatment in HaCaT cells remarkably down-regulated the ultraviolet B (UVB) irradiation-induced synthesis of interleukin-6 (IL-6), a pro-inflammatory cytokine associated with cutaneous inflammation. In an approach to identify the down-stream signaling mechanism by which 12-HHT down-regulates UVB-induced IL-6 synthesis in keratinocytes, we observed that 12-HHT inhibits the UVB-stimulated activation of p38 mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kappaB). In addition, we found that 12-HHT markedly up-regulates MAPK phosphatase-1 (MKP-1), a critical negative regulator of p38 MAPK. When MKP-1 was suppressed by siRNA knock-down, the 12-HHT-mediated inhibitory effects on the UVB-stimulated activation of p38 MAPK and NF-kappaB, as well as the production of IL-6, were attenuated in HaCaT cells. Taken together, our results suggest that 12-HHT exerts anti-inflammatory effect via up-regulation of MKP-1, which negatively regulates p38 MAPK and NF-kappaB, thus attenuating IL-6 production in UVB-irradiated HaCaT cells. Considering the critical role of IL-6 in cutaneous inflammation, our findings provide the basis for the application of 12-HHT as a potential anti-inflammatory therapeutic agent in UV-induced skin diseases.
Anti-Inflammatory Agents, Non-Steroidal/pharmacology
;
Cell Line
;
Dual Specificity Phosphatase 1/biosynthesis/genetics
;
Enzyme Activation
;
Fatty Acids, Unsaturated/*pharmacology
;
Humans
;
Interleukin-6/*biosynthesis
;
Keratinocytes/*metabolism/radiation effects
;
NF-kappa B/metabolism
;
RNA Interference
;
RNA, Small Interfering
;
Receptors, Leukotriene B4/genetics
;
Signal Transduction/drug effects
;
Skin Diseases/drug therapy
;
*Ultraviolet Rays
;
Up-Regulation
;
p38 Mitogen-Activated Protein Kinases/metabolism
4.The Effect of Intraperitoneal Hyperthermic Perfusion on the Postoperative Liver Function in Cancer Patient.
Keon Hee RYU ; Dong Eon MOON ; Jong Ho CHOI ; Yee Suk KIM ; Jae Yong SHIM ; Oh Kyung KWON ; Cheol Joo PARK ; Sung Nyeon KIM
Korean Journal of Anesthesiology 1998;34(5):1014-1020
BACKGROUND: Intraperitoneal hyperthermic perfusion (IPHP) has been introduced in clinical practice to improve the survival of cancer patients. But despite of this advantage, postoperative hepatic dysfunction may occur more severely after IPHP than general anesthesia. The protective mechanism of liver is destroyed by hyperthermia as the result. The purpose of this study is to evaluate the effect of intraperitoneal hyperthermic perfusion on the postoperative liver function in cancer patients. METHODS: Sixty patients with ovarian cancer were divided into two groups; 30 patients undergone only radical hysterectomy (control group), and 30 patients undergone radical hysterectomy combined with IPHP (IPHP group). Anesthesia was performed with enflurane-N2O-O2 in both groups. Serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and albumin levels were evaluated before anesthesia, 1, 3, 5, 7, 10 and 14th days after surgery on both groups. RESULTS: Postoperative SGOT levels were increased on 1, 3, 5, 7, 10 and 14th days in both groups, and on 1, 3 and 5 days postoperatively were increased more significantly in IPHP group than control group, but there were no significant difference between both groups after post-operative 7 days. SGPT levels were increased more significantly on 1, 3 and 5 days postoperatively in IPHP group than control group. Albumin levels were decreased more significantly on 1 and 3 days postoperatively in IPHP group than control group. CONCLUSION: We consider that postoperative liver function in cancer patients is influenced by the intraperitoneal hyperthermic perfusion.
Alanine Transaminase
;
Anesthesia
;
Anesthesia, General
;
Aspartate Aminotransferases
;
Fever
;
Humans
;
Hysterectomy
;
Liver*
;
Ovarian Neoplasms
;
Perfusion*
5.Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea: A Multicenter Retrospective Cohort Study.
Yong Soo KWON ; Yee Hyung KIM ; Jae Uk SONG ; Kyeongman JEON ; Junwhi SONG ; Yon Ju RYU ; Jae Chol CHOI ; Ho Cheol KIM ; Won Jung KOH
Journal of Korean Medical Science 2014;29(9):1226-1231
The data regarding risk factors for death during tuberculosis (TB) treatment are inconsistent, and few studies examined this issue in Korea. The purpose of this study was to evaluate baseline prognostic factors for death during treatment of adult patients with pulmonary TB in Korea. A multicenter retrospective cohort study of 2,481 patients who received TB treatment at eight hospitals from January 2009 to December 2010 was performed. Successful treatment included cure (1,129, 45.5%) and treatment completion (1,204, 48.5%) in 2,333 patients (94.0%). Unsuccessful treatment included death (85, 3.4%) and treatment failure (63, 2.5%) occurred in 148 patients (6.0%). In multivariate analysis, male sex, anemia, dyspnea, chronic heart disease, malignancy, and intensive care unit (ICU) admission were significant risk factors for death during TB treatment. Therefore, male sex, anemia, dyspnea, chronic heart disease, malignancy, and ICU admission could be baseline prognostic factors for death during treatment of adult patients with pulmonary TB in Korea.
Adult
;
Aged
;
Anemia/complications
;
Antitubercular Agents/*therapeutic use
;
Cohort Studies
;
Dyspnea/complications
;
Female
;
Heart Diseases/complications
;
Humans
;
Intensive Care Units
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasms/complications
;
Prognosis
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Sex Factors
;
Treatment Outcome
;
Tuberculosis/complications/*drug therapy/mortality
6.Sonographic Appearance of a Solitary Intramuscular Cysticercosis: A Case Report.
Ju Hee MOON ; Seung Ho JOO ; Joo Eun SHIM ; Yee Jeong KIM ; Hyun Cheol OH ; Tae Hwan KIM
Journal of the Korean Society of Medical Ultrasound 2009;28(1):51-54
The development of antiparasitic drugs and public health strategies has reduced the prevalence of cysticercosis in South Korea. In contrast, the disease is still endemic in Southeast Asia. The influx of immigrants from endemic areas has been on the increase. We report the sonographic and pathological findings of cysticercosis that presented as an intramuscular solitary mass in a 27-year-old Philippine woman.
Adult
;
Antiparasitic Agents
;
Asia, Southeastern
;
Cysticercosis
;
Emigrants and Immigrants
;
Humans
;
Prevalence
;
Public Health
;
Republic of Korea
7.The Value of Brachial-Ankle Pulse Wave Velocity as a Predictor of Coronary Artery Disease in High-Risk Patients.
Won Woo SEO ; Hyuk Jae CHANG ; IkSung CHO ; Yeon Yee YOON ; Jung Won SUH ; Kwang Il KIM ; Yong Seok CHO ; Tae Jin YOUN ; In Ho CHAE ; Dong Ju CHOI ; Cheol Ho KIM ; Eun Ju CHUN ; Sang Il CHOI
Korean Circulation Journal 2010;40(5):224-229
BACKGROUND AND OBJECTIVES: Arterial stiffness has been known as an independent contributory factor for coronary artery disease (CAD). Brachial-ankle pulse wave velocity (baPWV) is widely used as a simple noninvasive measure of arterial stiffness. The aim of our study was to test whether baPWV had predictive value for CAD in the subset of patients with high pretest probability. SUBJECTS AND METHODS: We enrolled 174 consecutive patients who were referred for evaluation of suspected CAD, and who underwent both baPWV measurement and computed tomography (CT) for coronary artery calcium scoring (CACS) as part of a diagnostic work-up. Subsequently, 160 of those patients underwent invasive coronary angiography. The CAD indices consisted of 1) CACS, 2) modified Gensini scoring system, and 3) presence of obstructive CAD and 4) multi-vessel obstructive CAD. RESULTS: baPWV correlated with CACS (r=0.25, p=0.001), but not with modified Gensini scoring (r=0.10, p=0.19). However, after adjustment for factors influencing PWV, baPWV no longer correlated with CACS (r=0.14, p=0.14). By receiver operating characteristic (ROC) curve analysis, baPWV was neither a sensitive nor specific index for predicting the presence of obstructive CAD or multi-vessel obstructive CAD (sensitivity: 53% and 59%; specificity: 50% and 55%, respectively). CONCLUSION: Our findings demonstrated that baPWV is associated with CACS, however, this may be primarily attributed to common risk factors, such as age. Furthermore, baPWV may be of limited value in identifying patients at risk for CAD.
Calcium
;
Compliance
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Vessels
;
Humans
;
Pulse Wave Analysis
;
Risk Factors
;
ROC Curve
;
Vascular Stiffness
8.Feasibility of Non-TBI Conditioning with Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation in Lymphoid Malignancy.
Ho Cheol SHIN ; Yoo Jin LEE ; Joon Ho MOON ; Soo Jung LEE ; Byung Woog KANG ; Yee Soo CHAE ; Jong Gwang KIM ; Jun Young CHOI ; Jong Won SEO ; Yu Kyung KIM ; Jang Soo SUH ; Sang Kyun SOHN
The Korean Journal of Internal Medicine 2012;27(1):72-83
BACKGROUND/AIMS: This retrospective study evaluated the transplantation outcomes of patients with adult lymphoid malignancies who received chemotherapy-based conditioning with busulfan and fludarabine (BuFlu) and busulfan and cyclophosphamide (BuCy2). METHODS: Thirty-eight patients (34 with acute lymphoblastic leukemia and 4 with lymphoblastic lymphoma) were included in the current study. The conditioning regimen was BuCy2 for 14 patients and BuFlu for the remaining 24 patients. Eight and 13 patients were high risk disease in the BuCy2 and BuFlu groups, respectively. RESULTS: The cumulative incidence of grade II-IV acute graft-versus-host disease (GVHD) was 56.5% and 55.2% and that of extensive chronic GVHD 17.0% and 55.6% (p = 0.018) for the BuFlu and BuCy2 groups, respectively. The 3-year relapse rate was 27.8% and 31.4% and 3-year overall survival 34.3% and 46.8% for the BuFlu and BuCy2 groups, respectively. Treatment-related mortality (TRM) was significantly lower in the BuFlu group (16.9%) than in the BuCy2 group (57.1%, p = 0.010). In multivariate analyses, the BuFlu regimen was identified as an independent favorable risk factor for TRM (hazard ratio [HR], 0.036; p = 0.017) and extensive chronic GVHD (HR, 0.168; p = 0.034). CONCLUSIONS: Our BuFlu regimen would appear to be an acceptable conditioning option for lymphoid malignancies, including high-risk diseases. It was safely administered with a lower TRM rate than BuCy2 conditioning.
Adolescent
;
Adult
;
Busulfan/adverse effects/*therapeutic use
;
Chi-Square Distribution
;
Disease-Free Survival
;
Drug Therapy, Combination
;
Feasibility Studies
;
Female
;
Graft vs Host Disease/etiology
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Myeloablative Agonists/adverse effects/*therapeutic use
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/mortality/surgery/*therapy
;
Proportional Hazards Models
;
Republic of Korea
;
Retrospective Studies
;
Risk Assessment
;
Risk Factors
;
*Stem Cell Transplantation/adverse effects/mortality
;
Time Factors
;
Transplantation Conditioning/adverse effects/*methods/mortality
;
Transplantation, Homologous
;
Treatment Outcome
;
Vidarabine/adverse effects/*analogs & derivatives/therapeutic use
;
Young Adult
9.Clinical significance of nuclear factor kappaB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
Ho Cheol SHIN ; Jongwon SEO ; Byung Woog KANG ; Joon Ho MOON ; Yee Soo CHAE ; Soo Jung LEE ; Yoo Jin LEE ; Seoae HAN ; Sang Kyung SEO ; Jong Gwang KIM ; Sang Kyun SOHN ; Tae In PARK
The Korean Journal of Internal Medicine 2014;29(6):785-792
BACKGROUND/AIMS: This study investigated the expression of nuclear factor kappaB (NF-kappaB) and the chemokine receptor (CXCR4) in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. METHODS: Seventy patients with DLBCL and treated with rituximab-CHOP (R-CHOP) were included, and immunohistochemistry was performed to determine the expression of NF-kappaB (IkappaB kinase alpha, p50, and p100/p52) and CXCR4. To classify DLBCL cases as germinal center B-cell-like (GCB) and non-GCB, additional immunohistochemical expression of CD10, bcl-6, or MUM1 was used in this study. The expression was divided into two groups according to the intensity score (negative, 0 or 1+; positive, 2+ or 3+). RESULTS: The median age of the patients was 66 years (range, 17 to 87), and 58.6% were male. Twenty-seven patients (38.6%) had stage III or IV disease at diagnosis. Twenty-three patients (32.9%) were categorized as high or high-intermediate risk according to their International Prognostic Indexs (IPIs). The overall incidence of bone marrow involvement was 5.7%. Rates of positive NF-kappaB and CXCR4 expression were 84.2% and 88.6%, respectively. High NF-kappaB expression was associated with CXCR4 expression (p = 0.002), and 56 patients (80.0%) showed coexpression. However, the expression of NF-kappaB or CXCR4 was not associated with overall survival and EFS. On multivariate analysis that included age, gender, performance status, stage, and the IPI, no significant association between the grade of NF-kappaB or CXCR4 expression and survival was observed. CONCLUSIONS: The current study suggests that the tissue expression of NF-kappaB and CXCR4 may not be an independent prognostic marker in DLBCL patients treated with R-CHOP.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Antibodies, Monoclonal, Murine-Derived/administration & dosage
;
Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
;
Chi-Square Distribution
;
Cyclophosphamide/administration & dosage
;
Disease Progression
;
Disease-Free Survival
;
Doxorubicin/administration & dosage
;
Female
;
Humans
;
Immunohistochemistry
;
Kaplan-Meier Estimate
;
Lymphoma, Large B-Cell, Diffuse/chemistry/*drug therapy/mortality/pathology
;
Male
;
Middle Aged
;
Multivariate Analysis
;
NF-kappa B/*analysis
;
Neoplasm Staging
;
Predictive Value of Tests
;
Prednisone/administration & dosage
;
Proportional Hazards Models
;
Receptors, CXCR4/*analysis
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Treatment Outcome
;
Tumor Markers, Biological/*analysis
;
Vincristine/administration & dosage
;
Young Adult
10.The Need for a Well-Organized, Video-Assisted Asthma Education Program at Korean Primary Care Clinics.
Yee Hyung KIM ; Kwang Ha YOO ; Jee Hong YOO ; Tae Eun KIM ; Deog Kyeom KIM ; Yong Bum PARK ; Chin Kook RHEE ; Tae Hyung KIM ; Young Sam KIM ; Hyoung Kyu YOON ; Soo Jung UM ; I Nae PARK ; Yon Ju RYU ; Jae Woo JUNG ; Yong Il HWANG ; Heung Bum LEE ; Sung Chul LIM ; Sung Soo JUNG ; Eun Kyung KIM ; Woo Jin KIM ; Sung Soon LEE ; Jaechun LEE ; Ki Uk KIM ; Hyun Kuk KIM ; Sang Ha KIM ; Joo Hun PARK ; Kyeong Cheol SHIN ; Kang Hyeon CHOE ; Ho Kee YUM
Tuberculosis and Respiratory Diseases 2017;80(2):169-178
BACKGROUND: The purpose of this study was to assess the effect of our new video-assisted asthma education program on patients' knowledge regarding asthma and asthma control. METHODS: Adult asthmatics who were diagnosed by primary care physicians and followed for at least 1 year were educated via smart devices and pamphlets. The education sessions were carried out three times at 2-week intervals. Each education period lasted at most 5 minutes. The effectiveness was then evaluated using questionnaires and an asthma control test (ACT). RESULTS: The study enrolled 144 patients (mean age, 56.7±16.7 years). Half of the patients had not been taught how to use their inhalers. After participating in the education program, the participants' understanding of asthma improved significantly across all six items of a questionnaire assessing their general knowledge of asthma. The proportion of patients who made errors while manipulating their inhalers was reduced to less than 10%. The ACT score increased from 16.6±4.6 to 20.0±3.9 (p<0.001). The number of asthmatics whose ACT score was at least 20 increased from 45 (33.3%) to 93 (65.3%) (p<0.001). The magnitude of improvement in the ACT score did not differ between patients who received an education session at least three times within 1 year and those who had not. The majority of patients agreed to the need for an education program (95.8%) and showed a willingness to pay an additional cost for the education (81.9%). CONCLUSION: This study indicated that our newly developed education program would become an effective component of asthma management in primary care clinics.
Adult
;
Asthma*
;
Education*
;
Humans
;
Nebulizers and Vaporizers
;
Pamphlets
;
Physicians, Primary Care
;
Primary Health Care*